Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia

被引:194
作者
Sasu, Barbra J. [1 ]
Cooke, Keegan S. [1 ]
Arvedson, Tara L. [1 ]
Plewa, Cherylene [2 ]
Ellison, Aaron R. [2 ]
Sheng, Jackie [2 ]
Winters, Aaron [2 ]
Juan, Todd [2 ]
Li, Hongyan [3 ]
Begley, C. Glenn [1 ]
Molineux, Graham [1 ]
机构
[1] Amgen Inc, Dept Hematol Oncol, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Dept Prot Sci, Thousand Oaks, CA 91320 USA
[3] Amgen Inc, Dept Pharmacokinet & Drug Metab, Thousand Oaks, CA 91320 USA
关键词
RECOMBINANT-HUMAN-ERYTHROPOIETIN; C-REACTIVE PROTEIN; HEMODIALYSIS-PATIENTS; TRANSGENIC MICE; CHRONIC DISEASE; RHEUMATOID-ARTHRITIS; INTRACELLULAR IRON; DEFICIENCY ANEMIA; MOLECULAR CONTROL; HEPCIDIN;
D O I
10.1182/blood-2009-09-245977
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Iron maldistribution has been implicated in multiple diseases, including the anemia of inflammation (AI), atherosclerosis, diabetes, and neurodegenerative disorders. Iron metabolism is controlled by hepcidin, a 25-amino acid peptide. Hepcidin is induced by inflammation, causes iron to be sequestered, and thus, potentially contributes to AI. Human hepcidin (hHepc) overexpression in mice caused an iron-deficient phenotype, including stunted growth, hair loss, and iron-deficient erythropoiesis. It also caused resistance to supraphysiologic levels of erythropoiesis-stimulating agent, supporting the hypothesis that hepcidin may influence response to treatment in AI. To explore the role of hepcidin in inflammatory anemia, a mouse AI model was developed with heat-killed Brucella abortus treatment. Suppression of hepcidin mRNA was a successful anemia treatment in this model. High-affinity antibodies specific for hHepc were generated, and hHepc knock-in mice were produced to enable antibody testing. Antibody treatment neutralized hHepc in vitro and in vivo and facilitated anemia treatment in hHepc knock-in mice with AI. These data indicate that antihepcidin antibodies may be an effective treatment for patients with inflammatory anemia. The ability to manipulate iron metabolism in vivo may also allow investigation of the role of iron in a number of other pathologic conditions. (Blood. 2010;115(17):3616-3624)
引用
收藏
页码:3616 / 3624
页数:9
相关论文
共 39 条
  • [1] Molecular control of iron metabolism
    Andrews, NC
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (02) : 159 - 169
  • [2] High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients
    Barany, P
    Divino, JC
    Bergstrom, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (04) : 565 - 568
  • [3] Bertero MT, 1997, HAEMATOLOGICA, V82, P375
  • [4] CARTWRIGHT G. E., 1966, SEMINARS HEMATOL, V3, P351
  • [5] Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey
    Coiffier, B
    Guastalla, JP
    Pujade-Lauraine, E
    Bastit, P
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (13) : 1617 - 1623
  • [6] Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
    Ganz, T
    [J]. BLOOD, 2003, 102 (03) : 783 - 788
  • [7] Molecular control of iron transport
    Ganz, Tomas
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (02): : 394 - 400
  • [8] RESPONSE OF ANEMIA IN RHEUMATOID-ARTHRITIS TO TREATMENT WITH SUBCUTANEOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN
    GUDBJORNSSON, B
    HALLGREN, R
    WIDE, L
    BIRGEGARD, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (06) : 747 - 752
  • [9] European Best Practice Guidelines 14-16 -: Inadequate response to epoetin
    Hörl, WH
    Jacobs, C
    Macdougall, IC
    Valderrábano, F
    Parrondo, I
    Thompson, K
    Carveth, BG
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 : 43 - 50
  • [10] Hepcidin Revisited, Disulfide Connectivity, Dynamics, and Structure
    Jordan, John B.
    Poppe, Leszek
    Haniu, Mitsuru
    Arvedson, Tara
    Syed, Rashid
    Li, Vivian
    Kohno, Hiko
    Kim, Helen
    Schnier, Paul D.
    Harvey, Timothy S.
    Miranda, Les P.
    Cheetham, Janet
    Sasu, Barbra J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (36) : 24155 - 24167